EICHOR
● Active Not Recruiting
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
Condition: Acute Gastroenteritis · Norovirus Acute Gastroenteritis · Sponsor: ModernaTX, Inc.
About this study
The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prevent protocol-defined moderate or severe norovirus acute gastroenteritis (AGE) associated with vaccine matched genotypes.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (283)
| Accel Research Sites - Achieve Clinical Research | Birmingham, Alabama, United States | — |
| Cullman Clinical Trials | Cullman, Alabama, United States | — |
| Alliance for Multispecialty Research, LLC | Daphne, Alabama, United States | — |
| ClinMed, LLC | Phoenix, Arizona, United States | — |
| DM Clinical - Phoenix | Phoenix, Arizona, United States | — |
| HOPE Research Institute | Phoenix, Arizona, United States | — |
| HOPE Research Institute | Phoenix, Arizona, United States | — |
| Abby's Research Institute | Phoenix, Arizona, United States | — |
| Headlands Research Scottsdale | Scottsdale, Arizona, United States | — |
| Scottsdale Clinical Trials | Scottsdale, Arizona, United States | — |
| Hope Research Institute - Tempe | Tempe, Arizona, United States | — |
| Arizona Liver Health | Tucson, Arizona, United States | — |
+ 271 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06592794